Dry aluminium hydroxide 200mg/magnesium trisilicate/sodium alginate 100mg/ simethicone 25mg
Vitamin / mineral / nutritional supplement
What it is used for
Therapeutic use is agent- and indication-specific within the class (Vitamin / mineral / nutritional supplement). Use according to culture results, national guidelines (Kenya STG/EML where applicable) and the current product SmPC. Dyspepsia, heartburn, and flatulence.
Warnings
[Dry aluminium hydroxide] Treat confirmed deficiency with monitored repletion. Avoid megadoses without indication. Iron: keep away from children (overdose lethal). [magnesium trisilicate] Treat confirmed deficiency with monitored repletion. Avoid megadoses without indication. Iron: keep away from children (overdose lethal). [alginate] WARNINGS: Professional Use Only If pregnant or breast-feeding, ask a health professional before use. In case of overdose, get medical help or contact a Poison Control Center right away. If condition worsens, seek medical attention. KEEP OUT OF REACH OF CHILDREN Do not use if tamper evident seal is broken or missing. Store in a cool place after opening [simethicone] Obtain allergy and medication history. Adjust for renal/hepatic impairment, pregnancy, lactation, extremes of age and interacting drugs. Use the lowest effective dose for the shortest appropriate duration. Monitor for expected class adverse effects.
Possible side effects
[Dry aluminium hydroxide] GI upset (iron, high-dose vitamin C). Hypercalcaemia (vitamin D excess). Neuropathy with B6 megadoses. Flushing (niacin). [magnesium trisilicate] GI upset (iron, high-dose vitamin C). Hypercalcaemia (vitamin D excess). Neuropathy with B6 megadoses. Flushing (niacin). [alginate] Adverse reactions vary by agent. Counsel on common predictable effects and serious warning symptoms (allergy, severe rash, jaundice, unusual bleeding, severe GI symptoms, neurological changes). Report suspected ADRs via national pharmacovigilance channels. [simethicone] Adverse reactions vary by agent. Counsel on common predictable effects and serious warning symptoms (allergy, severe rash, jaundice, unusual bleeding, severe GI symptoms, neurological changes). Report suspected ADRs via national pharmacovigilance channels.
Storage
Store as labelled. Keep out of reach of children.
No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.